133 related articles for article (PubMed ID: 3075051)
1. [Therapeutic prospects of interferon in patients with chronic myelocytic leukemia].
Podsiadło Z; Skotnicki AB; Blicharski J
Przegl Lek; 1988; 45(9):687-9. PubMed ID: 3075051
[No Abstract] [Full Text] [Related]
2. Combined therapy interferon and chemotherapy in chronic myelogenous leukemia.
Guilhot F; Dreyfus B; Desmarest MC; Giraud C; Huret JL; Brizard A; Tanzer J
Nouv Rev Fr Hematol (1978); 1989; 31(2):171-3. PubMed ID: 2771633
[TBL] [Abstract][Full Text] [Related]
3. Treatment of chronic myelogenous leukemia with interferons: hematologic, cellular, and genetic investigations.
Opalka B; Kloke O; Wandl U; Becher R; Niederle N
Haematol Blood Transfus; 1989; 32():134-8. PubMed ID: 2516494
[No Abstract] [Full Text] [Related]
4. [The treatment of chronic myeloid leukemia in chronic phase with interferons].
Guilhot F
Pathol Biol (Paris); 1988 Dec; 36(10):1179-81. PubMed ID: 3070457
[No Abstract] [Full Text] [Related]
5. CML: new biologic therapies, endpoints and questions.
Martin A; Cheson BD
Oncology (Williston Park); 1987 Sep; 1(7):12-3, 16. PubMed ID: 3152809
[No Abstract] [Full Text] [Related]
6. Activity of alpha-interferons in chronic myelogenous leukaemia.
Talpaz M
Br J Clin Pract Suppl; 1988 Mar; 62():13-5. PubMed ID: 3145008
[No Abstract] [Full Text] [Related]
7. Interferon alpha induced and maintained complete remission in chronic granulocytic leukemia in relapse after bone marrow transplantation.
Borgies P; Ferrant A; Delannoy A; Van den Berghe H; Michaux JL
Bone Marrow Transplant; 1989 Jan; 4(1):127-8. PubMed ID: 2647178
[TBL] [Abstract][Full Text] [Related]
8. [The use of interferon-alfa (reaferon) in patients with chronic myeloleukemia].
Machiulaĭtene ER; Lasunskaia EB; Nefedova IuB; Perekalina TA; Salogub GN; Poliakova LE
Ter Arkh; 1996; 68(10):44-7. PubMed ID: 9026942
[TBL] [Abstract][Full Text] [Related]
9. Treatment with natural human interferon alpha of a CML-patient with antibodies to recombinant interferon alpha-2b.
Freund M; von Wussow P; Knüver-Hopf J; Mohr H; Pohl U; Exeriede G; Link H; Wilke HJ; Poliwoda H
Blut; 1988 Nov; 57(5):311-5. PubMed ID: 3196882
[TBL] [Abstract][Full Text] [Related]
10. [The treatment of chronic myeloleukemia with recombinant alfa-2 interferon].
Strozha I; Petukhov V; Bondare D; Feldmane G; Duks A; Teilane I; Medne I; Mauritsas M; Grinberga L
Ter Arkh; 1993; 65(10):62-6. PubMed ID: 8296238
[TBL] [Abstract][Full Text] [Related]
11. Minimal residual disease in interferon-treated chronic myelogenous leukemia: results and pitfalls of analysis based on polymerase chain reaction.
Dhingra K; Kurzrock R; Kantarjian H; Baine R; Eastman PS; Ku S; Gutterman JU; Talpaz M
Leukemia; 1992 Aug; 6(8):754-60. PubMed ID: 1640725
[TBL] [Abstract][Full Text] [Related]
12. Interferon alpha-2a to control thrombocytosis in chronic myelogenous leukemia and essential thrombocythemia.
Jootar S
Asian Pac J Allergy Immunol; 1989 Dec; 7(2):103-5. PubMed ID: 2624663
[TBL] [Abstract][Full Text] [Related]
13. Persistent suppression of granulo-erythropoietic precursor cells in alpha interferon treated CML patients undergoing autologous stem cell transplantation: in vitro and clinical results.
De Fabritiis P; Sandrelli A; Meloni G; De Felice L; Di Matteo G; Alimena G; Montefusco E; Defazio D; Mandelli F
Prog Clin Biol Res; 1990; 333():225-33. PubMed ID: 2308984
[No Abstract] [Full Text] [Related]
14. Juvenile chronic myelogenous leukemia: therapeutic trial with interferon alpha 2B.
Agarwal BR; Gulvady A; Joshi K; Khemani S; Currimbhoy ZE
Indian Pediatr; 1995 Sep; 32(9):1002-4. PubMed ID: 8935266
[No Abstract] [Full Text] [Related]
15. Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia.
Hughes TP; Kaeda J; Branford S; Rudzki Z; Hochhaus A; Hensley ML; Gathmann I; Bolton AE; van Hoomissen IC; Goldman JM; Radich JP;
N Engl J Med; 2003 Oct; 349(15):1423-32. PubMed ID: 14534335
[TBL] [Abstract][Full Text] [Related]
16. Juvenile chronic myeloid leukaemia and alpha-interferon.
Aricò M; Nespoli L; Caselli D; Bonetti F; Porta FA; Burgio GR
Eur J Pediatr; 1989 Jan; 148(4):379-80. PubMed ID: 2707286
[No Abstract] [Full Text] [Related]
17. Use of quantitative polymerase chain reaction to monitor residual disease in chronic myelogenous leukemia during treatment with interferon.
Lion T; Gaiger A; Henn T; Hörth E; Haas OA; Geissler K; Gadner H
Leukemia; 1995 Aug; 9(8):1353-60. PubMed ID: 7643624
[TBL] [Abstract][Full Text] [Related]
18. [Experience with the use of reaferon (alfa 2-interferon) for treating patients with chronic myeloleukemia].
Abdulkadyrov KM; Moiseev SI; Shcherbakova EG; Balashova VA; Glazanova TV; Rukavitsyn OA; Martynkevich IS; Gritsaev SV; Blinov MN
Ter Arkh; 1995; 67(6):59-63. PubMed ID: 7667786
[TBL] [Abstract][Full Text] [Related]
19. [Recombinant alpha-interferon (reaferon) in the treatment of patients with chronic myeloleukemia].
Khoroshko ND; Savchenko VG; Kholopova EI; Kotel'nikov VM; Zakharova AV; Semenova EA; Marchenko VI
Ter Arkh; 1990; 62(7):41-7. PubMed ID: 2251664
[TBL] [Abstract][Full Text] [Related]
20. Sequential treatment of Ph-positive chronic myeloid leukemia with interferon gamma and interferon alpha.
Russo D; Fanin R; Zuffa E; Damiani D; Gallizia C; Michieli M; Testoni N; Benfenati D; Visani G; Zaccaria A
Haematologica; 1990; 75(4):334-9. PubMed ID: 2125966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
